IOF presents eight young investigator awards to researchers across the world

NewsGuard 100/100 Score

Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.

The presentations were made on September 5th during the IOF Regionals 2nd Asia-Pacific Osteoporosis & Bone Meeting and Australian and New Zealand Bone & Mineral Society Annual Scientific Meeting, with the Japanese Society for Bone and Mineral Research. The meeting is being held until September 8 at the Gold Coast Convention Center in Queensland Australia.

The winning investigators and the topic of their research presentations are as follows:

  • Agnieszka Arthur (Australia): The role of EPHB/EPHRINB molecules in fracture repair
  • Haslinda Gould (Australia): Normative ultrasound data for population-based Australian men and women: The Geelong Osteoporosis Study
  • Shozo Itoh (Japan): Functional redundancy of GSK-3α and GSK-3β to control chondrocyte differentiation through phosphorylation of RelA/NF-κB p65
  • Masanobu Kawai (Japan): Brown adipose tissue dysfunction causes bone loss
  • Arei Miyamoto (Japan) : Double stranded RNA increases bone mass in osteoporosis model mice by inhibiting osteoclastogenesis via interferon-β/STAT1 pathway
  • Krishanu Mondal (India): A randomized controlled trial on safety and efficacy of single intramuscular vs staggered oral dose of 600,000 IU vitamin D in treatment of nutritional rickets
  • Zhifeng Sheng (China): Serum sclerostin level was positively correlated with bone mineral density in central south Chinese postmenopausal women
  • Rikako Takashima (Japan): The transcription factor Arid5b modulates endochondral bone formation in cooperation with Sox9

Source: International Osteoporosis Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings